Reducing 30-day Readmissions in Patients With Heart Failure Through Pharmacist Discharge Medication Services

Not Applicable

Completed

• Conditions: Patient Readmission; Heart Failure

• Registration Number: NCT02752997
• Lead Sponsor: Mayo Clinic

Brief Summary

Patients admitted for heart failure that are provided discharge medication services by a pharmacist are less likely to be readmitted within 30 days of primary admission.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-12
• Primary Completion: 2016-03
• Study Completion: 2016-03
• Status Verified: 2016-04
• Study First Submitted: 2016-04-14
• Study First Submitted QC: 2016-04-23
• Last Update Submitted: 2016-04-23
• Study First Posted: 2016-04-27
• Last Update Posted: 2016-04-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

• Diagnosis of heart failure, discharged from any medical service

Exclusion Criteria

• Unwilling to participate, discharged to nursing/rehab facility, non-English speaking, resident unavailable

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: FACTORIAL

Primary Outcome Measures

Name	Time	Method
Number of patients readmitted to the hospital within 30 days of primary heart failure admission	30 Days	Fisher's T-test

Secondary Outcome Measures

Name	Time	Method
Number of patients who visit the emergency department within 30 days of primary heart failure admission	30 Days	Fisher's T-test
Number of short term goals set by patient's at discharge and the number of short term goals met by patient's at the 7-10 follow up phone call.	30 days	Number of short term goals set will be compared to the number of goals patients achieved, comparison will be calculated by percentage
Number of medication discrepancies identified and the number of medication discrepancies resolved by the pharmacist at discharge.	30 Days	Fisher's T-test

Trial Locations

Locations (1)

Mayo Clinic Health System - Franciscan Healthcare; 🇺🇸 La Crosse, Wisconsin, United States